Cite
HARVARD Citation
Nino, A. et al. (2018). Weekly glucagon‐like peptide‐1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled study. Journal of diabetes investigation. 9 (3), pp. 558-566. [Online].